Natalie Kirilichin
Assistant Professor of Emergency Medicine
Natalie Kirilichin, MD, MPH, is a board-certified attending emergency medicine physician and assistant professor with the George Washington University Department of Emergency Medicine. As faculty, she works at GWU and The Walter Reed National Military Medical Center clinically caring for patients and teaching/training medical students and residents. Her education leadership roles include co-directing the GWU MFA Health Policy Fellowship and the Health Policy Scholarly Concentration Program at the School of Medicine. Dr. Kirilichin is also core faculty for the Residency Fellowship in Health Policy.
Dr. Kirilichin developed an interest in behavioral health while working for the U.S. Senate Committee on Health, Education, Labor and Pensions (HELP) as a health policy fellow. There, her portfolio included mental health and substance abuse policy, and her work supported Comprehensive Addiction and Recovery Act passage and the opioid funding provisions of 21st Century Cures. Dr. Kirilichin went on to join National Safety Council, a nonprofit that eliminates preventable deaths through leadership, research, education and advocacy. She serves as a medical advisor and member of the Physician Speaker’s Bureau for this organization, working with colleagues in multiple disciplines across the country on constructive interventions to combat the opioid epidemic.
Dr. Kirilichin received her undergraduate degree (BS, Biology) from Georgetown University, and remained at Georgetown’s School of Medicine to complete her MD. She earned her MPH from the GWU Milken Institute School of Public Health. During her residency at University of Chicago Hospitals, she worked with the American College of Emergency Physicians (ACEP) in an advocacy capacity. She currently serves as President of the DC Chapter of this organization and as a member of the Pain Management and Addiction Medicine Section. Finally, Dr. Kirilichin serves on the Advisory Committee for DC Health’s Prescription Drug Monitoring Program (PDMP).
Assistant Professor of Emergency Medicine
Natalie Kirilichin, MD, MPH, is a board-certified attending emergency medicine physician and assistant professor with the George Washington University Department of Emergency Medicine. As faculty, she works at GWU and The Walter Reed National Military Medical Center clinically caring for patients and teaching/training medical students and residents. Her education leadership roles include co-directing the GWU MFA Health Policy Fellowship and the Health Policy Scholarly Concentration Program at the School of Medicine. Dr. Kirilichin is also core faculty for the Residency Fellowship in Health Policy.
Dr. Kirilichin developed an interest in behavioral health while working for the U.S. Senate Committee on Health, Education, Labor and Pensions (HELP) as a health policy fellow. There, her portfolio included mental health and substance abuse policy, and her work supported Comprehensive Addiction and Recovery Act passage and the opioid funding provisions of 21st Century Cures. Dr. Kirilichin went on to join National Safety Council, a nonprofit that eliminates preventable deaths through leadership, research, education and advocacy. She serves as a medical advisor and member of the Physician Speaker’s Bureau for this organization, working with colleagues in multiple disciplines across the country on constructive interventions to combat the opioid epidemic.
Dr. Kirilichin received her undergraduate degree (BS, Biology) from Georgetown University, and remained at Georgetown’s School of Medicine to complete her MD. She earned her MPH from the GWU Milken Institute School of Public Health. During her residency at University of Chicago Hospitals, she worked with the American College of Emergency Physicians (ACEP) in an advocacy capacity. She currently serves as President of the DC Chapter of this organization and as a member of the Pain Management and Addiction Medicine Section. Finally, Dr. Kirilichin serves on the Advisory Committee for DC Health’s Prescription Drug Monitoring Program (PDMP).